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Atrial fibrillation (AF) is the most common abnormal heart rhythm and the single biggest cause
of stroke. Ablation, destroying regions of the atria, is applied largely empirically and can be curative
but with a disappointing clinical success rate. We design a simple model of activation wavefront
propagation on an anisotropic structure mimicking the branching network of heart muscle cells. This
integration of phenomenological dynamics and pertinent structure shows how AF emerges sponta-
neously when the transverse cell-to-cell coupling decreases, as occurs with age, beyond a threshold
value. We identify critical regions responsible for the initiation and maintenance of AF, the ablation
of which terminates AF. The simplicity of the model allows us to calculate analytically the risk of
arrhythmia and express the threshold value of transversal cell-to-cell coupling as a function of the
model parameters. This threshold value decreases with increasing refractory period by reducing the
number of critical regions which can initiate and sustain micro-reentrant circuits. These biologically
testable predictions might inform ablation therapies and arrhythmic risk assessment.
Atrial fibrillation (AF) is a poorly understood arrhyth-
mia where multiple activation wavefronts are observed
to propagate continuously in the atrial muscle tissue in
an apparently random manner [1]. The activation wave-
fronts meander, divide and collide with mutual extinction
and re-initiation. This manifests in patients as episodes
of variable duration, from short self-terminating episodes
(paroxysmal AF), which typically get longer with time to
become self-sustaining (persistent AF) [2]. The incidence
of AF increases with age and is strongly associated with
the accumulation of fibrosis [3], however, the exact mech-
anisms underlying AF are still not understood.
The relationship between heart muscle architecture
(structure) and the propagation of activation wavefronts,
i.e., the relationship between structure and function, may
be a key mechanism. Rotating spiral wavefronts of activ-
ity (rotors) have been observed in isolated cardiac tissue
[4] and recently in human AF [5], suggesting critical re-
gions for persistence of AF. But why rotors should form
and their relationship to the underlying structure and
its arrhythmogenic characteristics are unknown. Hetero-
geneity in structural and electrophysiological tissue prop-
erties (e.g. fibrosis [6], orifices [7], action potential du-
ration [8], restitution [9], tissue thickness [10]) have all
been implicated in the perpetuation of AF.
Ablating atrial tissue extensively and empirically via
catheter electrodes may cure AF in some cases [7, 11], but
an inability to identify the specific regions critical to the
persistence of AF has resulted in failure to improve on
disappointing clinical outcomes. Thus, enhancing mech-
anistic understanding, identification of critical causative
regions and prediction of arrhythmic risk for preventative
strategies requires a novel approach.
Heart muscle cells are discrete and so it is natural to
use cellular automata to model activation wavefronts as
was done in some of the earliest mathematical models of
AF [12, 13]. These studies investigated the effect of het-
erogeneity in functional parameters (e.g., refractory pe-
riod) and macroscopic obstacles on the dynamics of wave-
fronts. In agreement with physiological experiments, the
studies showed that an increase in hetereogeneity in re-
fractory period resulted in greater wavefront complexity.
Bub, Shrier and Glass devised cellular automata mod-
els of cardiac conduction and experimentally compared
the behaviour of the model to cardiac cell monolayers
[14, 15]. Bub et al. have also investigated the relation-
ship between structural heterogeneity and the stability
of activation wavefronts in isotropically coupled tissue
for comparison with cardiac monolayers [16].
In contrast, we have investigated the effect of
anistropic structural heterogeneity in the underlying lat-
tice of cells to mimic the lateral uncoupling of myocar-
dial strands by fibrosis in cardiac muscle [3]. The level
of structural heterogeneity is controlled by ν, a model
parameter that determines the fraction of cells with lat-
eral cell-to-cell couplings. Qualitatively, the model re-
produces many of the known characteristics of real AF.
For example, we find that with low levels of structural
heterogeneity wave propagation remains planar. As the
level of structural heterogeneity is increased beyond a
threshold value, we observe spontaneous localised dis-
ruption of propagation and progressive degeneration to
fibrillation, either self terminating or sustained. Hence,
the simple phenomenological model reproduces the ob-
servation that age related changes, that is, an increase
in structural anisotropy [3, 17], might spontaneously in-
duce and sustain AF. We stress that AF behaviour is
initiated spontaneously in this model as a result of the
pertinent underlying structure of the tissue as opposed
to a combination of rapidly paced tissue and functional
heterogeneity or macroscopic obstacles.
The simplicity of the model provides mechanistic in-
sight into the initiation and maintenance of AF. We can
characterise and identify the composition of local regions
2critical to the initiation and maintenance of AF and show
that ablation of such critical regions may terminate AF.
Furthermore, we predict the existence of a critical level
of heterogeneity beyond which AF occurs. Due to the
simplicity of the model, we can analytically calculate
the risk of AF as a function of model parameters. This
analytic expression reveals that the threshold value of
structural anisotropy decreases with increasing refractoy
period. Bringing the threshold ν⋆ below ν by increas-
ing the refractory period prevents micro-reentry circuits
from persisting or forming because the wavefront in the
circuit collides with its unexcitable tail.
Our model of AF is complementary to biophysical
models where subcellular processes, such as ion chan-
nel activity, are taken into account [18, 19]. Biophysical
models of cardiac tissue commonly consist of a system
of partial differential equations (PDEs), known as the
bidomain model, coupled nonlinearly to a system of or-
dinary differential equations modelling the cell membrane
dynamics. With simplification such biophysical models
are amenable to analytic calculations [20]. E.g., Keener
[21, 22] and Biktashev [23] have derived analytic calcu-
lations for spiral wave dynamics on a reduced form of
these equations. PDE based models assume a continu-
ous medium while our main investigation is on the effects
of anisotropic structural heterogeneity for which the dis-
creteness of the tissue may be important [24–26].
A healthy atrial area is L
′
×L
′
≈ 20cm2 [27, 28]. Atrial
muscle tissue consists of nearly cylindrical myocytes of
length ∆x′ ≈ 100µm and diameter ∆y′ ≈ 20µm packed
in an irregular brick-wall like pattern [29, 30]. Cells are
coupled primarily from end-to-end along the longitudi-
nal axis of the cell with little side-to-side coupling, thus
forming a branching cable-like structure [29, 31]. The
structure and strength of these connections can change,
e.g., fibrosis can uncouple cells, primarily in a side-to-
side fashion [29]. To represent this branching network of
interacting cells, each cell is coupled to its neighbours lon-
gitudinally and to its neighbours transversally with prob-
ability ν. Structurally, the substrate can be pictured as
a set of aligned longitudinal cables of single cell thickness
which are coupled to neighbouring cables with frequency
ν. The structure is a 2D sheet. A 2D sheet is a good first
approximation because the atrial muscle wall is relatively
thin, 2.5mm [31]. However, one might extend the model
to 3D by coupling adjacent 2D sheets of tissue. To mimic
the basic topological features of an atrium we apply peri-
odic boundary conditions vertically and open boundary
conditions horizontally to the 2D model. This provides
a cylindrical topology which is a convenient substrate to
study the evolution of wavefronts as our focus is on in-
vestigating the effects of increasing anisotropic structural
heterogeneity, rather than the detailed effects of atrial
anatomy. Once the substrate is generated, it remains
fixed throughout the numerical simulation. Thus cou-
pling related changes in the structure are incorporated
into the substrate by the single variable ν.
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FIG. 1: (a-c) A coupling is represented by a link between
two cells. Cells are always coupled longitudinally and with
frequency ν transversely. (a-b) A resting cell (black) will be-
come excited (white) in the next time step if at least one of
its neighbouring coupled cells are excited. (b-c) Once a cell is
excited it will enter a refractory state (grey scale) for a dura-
tion of time τ . (d) The time course of a cell once it has been
excited by an excited neighbouring coupled cell
The coordinated contraction of the heart is a result of
a regular propagating wavefront of activation originat-
ing at the heart’s natural pacemaker. The ionic currents
which determine the activation of a cell are not explicitly
considered in the model. In its simplest representation, a
cell may be in one of three states: resting (repolarised),
excited (depolarising) or refractory, see Fig. 1. An ex-
cited cell induces neighbouring resting cells to become
excited and the wavefront is a coherent propagation of
this excitation throughout the tissue. The time taken for
a cell to depolarise, ∆t′ ≈ 0.6ms, is much shorter than
the refractory period, τ ′ ≈ 150ms. Cells along the left
boundary are pacemakers and self-excite at a fixed period
T ′ = 300-1000ms to mimic normal cardiac rhythm.
Cellular electrical dysfunction of any cause introduces
a degree of noise into the excitation process. A fraction δ
of randomly chosen cells in the substrate are assigned to
be dysfunctional. Such cells have a finite probability, ǫ,
of not exciting in response to an excited neighbour and
hence can block the transmission of excitation.
Translating real tissue values into the model yields
L = L
′
/∆x′ = 1000. We coarse-grain the model by tak-
ing ∆x′ → b∆x′, where b is the number of cells within
a unit of space in the model. As the conduction ve-
locity θ′x = ∆x
′/∆t′ ≈ 0.2ms−1 is fixed we also get
∆t′ → b∆t′. We take b = 5 which gives L = 200 and
τ = τ ′/(b∆t′) = 50. The evolution of the system varies
depending on the fractions of transverse connections ν
and dysfunctional cells δ which are the only remaining
parameters. Coarse-graining the transversal connections
gives: ν → 1 − (1 − ν)b as this is the probability that
a group of b cells have at least one vertical connection
between them. The parameters of the model are system
size L×L, refractory period τ , the fraction of dysfunc-
tional cells δ, the probability of dysfunction ǫ = 0.05, the
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FIG. 2: Initiation and self-termination of fibrillation in a sim-
ulation with L = 200, τ = 50, ǫ = 0.05, δ = 0.05, and
ν = 0.18. See Supp. Fig. 1 for the full image and animation.
The pacemaker cells self-activate with a period of T = 220.
(a) A planar wavefront induced by pacemaker cells along the
left boundary a time t0. (b) An opening occurs in the re-
fractory wake (i.e, wave-break) and a wave of excitation leaks
back on itself. (c) A reentrant circuit forms as a result of this
breakthrough. (d) The reentrant circuit self-terminates and
planar wave propagation resumes. (e) A critical region which
can induce a rotor. The dysfunctional cell (dotted boundary)
in the bottom cable may block the propagation wavefront.
When the wavefront in the top cable reaches the rightmost
vertical connection, it induces activity in the bottom cable
that will also propagate retrograde. If the relevant path length
(red line) of the circuit is greater than the refractory period,
the cell to the left of the dysfunctional cell will be in a resting
state when the retrograde wavefront arrives and a reentrant
circuit of activation forms. The reentrant circuit terminates
when the dysfunctional cell blocks the retrograde wavefront.
This is the simplest example of a critical region which will
induce fibrillation-like behaviour in the model.
period of pacing T = T ′/(b∆t′) = 220 using T ′ = 660ms
and the fraction of transverse connections ν.
When ν = 1, mimicking neonatal tissue in humans and
other mammals, we observe regular wavefronts for all δ,
consistent with the rarity of AF observed in children.
We now investigate the effect of structural heterogene-
ity (ν < 1). For simplicity, we consider a fixed fraction
of dysfunctional cells (δ = 0.05) leaving the fraction of
transverse connections, ν, as the only control parameter.
For large fractions of transverse connections (ν & 0.21)
we only observe planar wavefronts. However, as ν is
decreased, mimicking the onset of fibrotic interference
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FIG. 3: (a) A phase diagram of the model with L = 200,
τ = 50, ǫ = 0.05, and δ = 0.05. Pacemaker cells self-
activate with a period of T = 220. As ν decreases from
1, a transition from planar wavefronts (C) to a few self-
terminating reentrant circuits (B) occurs. As ν is decreased
below ν⋆ ≈ 1 − (δL2)−
1
τ ≈ 0.14 the system develops multiple
self-sustaining reentrant circuits (A). The red line is the an-
alytically calculated probability Prisk = 1 − [1−(1− ν)
τ ]δL
2
of having at least one fibrillation-inducing structure, see Fig.
2(e). The solid blue circles represent the average duration
that a system displays non-planar wavefronts, averaged over
50 realisations of duration 106 time steps and error bars rep-
resent one standard error of the mean. (b-d) Realisations of
systems with ν = 0.9 - planar behaviour, ν = 0.2 - single self-
terminating rotor and ν = 0.15 - multiple self-terminating
rotors. See Supp. Fig. 2 for the full image.
of lateral cell-to-cell coupling, the branching nature be-
comes more prominent and circuits of activity may form
spontaneously by wavelets of excitation leaking back
through the refractory wake of the wavefront, see Fig.
2(a-c). The associated fibrillation may self-terminate, see
Fig. 2(d), or become persistent. Together the structural
heterogeneity and dysfunctional cells may create a reen-
trant circuit that constitutes a rotor, see Fig. 2(e).
Hence, the parameter space ν may be divided into a
rotor forming range and a stable range in which no ro-
tors form, see Fig. 3. The frequency of formation and the
temporal duration of rotors increases sharply from zero as
the fraction of transverse connections ν decreases below
a threshold value ν⋆ ≈ 0.14. Only when ν is sufficiently
small will the relevant path length of the reentrant cir-
cuits exceed the refractory period, which is a necessary
condition to sustain a rotor, see Fig. 2(e). Decreasing ν
results in rotors forming and disassociating more rapidly
resulting in a fibrillatory state, see Fig. 3. This mimics
the natural onset of AF and its transition to paroxysmal
and persistent atrial fibrillation. Moreover this is con-
sistent with the increase of AF incidence with advancing
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FIG. 4: (a) A rotor due to a critical structure. (b) An abla-
tion is made by rendering a 20 × 20 section of tissue around
the critical structure unexcitable (cross hatched red). (c-f)
The ablation terminates the reentrant circuit and the system
returns to a planar wavefront phase. See Supp. Fig. 3 for the
full image and animation.
age. The critical regions forming a simple reentrant cir-
cuit as displayed in Fig. 2(e) are primarily responsible for
the fibrillation observed in the model.
In our model, we can analytically calculate the risk
of developing atrial fibrillation. We identify the risk of
developing atrial fibrillation with the probability that the
L×L system has at least one portion of the reentrant
circuit as displayed in red in Fig. 2(e). The probability
that a cell has at least one transverse coupling is pν =
1−(1− ν)
2
. Given an arbitrary dysfunctional cell i, let ℓi
denote the distance from that cell to its first neighbour
to the right that has at least one transverse coupling.
Hence, the probability that ℓi <
τ
2
(assuming τ is even)
P
(
ℓi <
τ
2
)
=
τ
2
−1∑
ℓi=0
(1− pν)
ℓipν = 1− (1− ν)
τ
. (1)
The average no. of dysfunctional cells is δL2 and Prisk is
the complement of all dysfunctional cells having li <
τ
2
:
Prisk=1−[1−(1−ν)
τ ]
δL2
=1−[1−(1−ν)
θ′xτ
′
b∆x′ ]
δL
′ 2
b2∆x′∆y′ . (2)
The first expression is in dimensionless units, while
the second expression is in units with dimensions where
∆t′ = ∆x′/θ′x where θ
′
x is the conduction velocity in the
longitudinal direction.
The analytically calculated risk’s fit to the data, see
solid red line in Fig. 3(a), confirms that the critical re-
gions shown in Fig. 2(e) drive fibrillation in the model.
By rendering the region containing this structure unex-
citable, mimicking ablation, we find that the rotor ter-
minates and planar wavefronts reappear, representing a
return to regular cardiac rhythm, see Fig. 4(a-f).
The model displays a sharp transition from regular to
fibrillatory behaviour as a function of the control pa-
rameter ν. The existence of the transition is techni-
cally a finite-size effect because as the system size in-
creases, the planar wavefront range (C) of the phase
diagram decreases and will, eventually disappear for
L → ∞. However, the threshold value ν⋆, defined
by the point of steepest slope of Prisk, increases ex-
tremely slowly with system size as ν∗ ≈ 1 − (δL2)−
1
τ ≈
1−(δL′
2
/b2∆x′∆y′)−b∆x
′/θx
′τ ′, for τ ≫ 1 and δL2τ ≫ 1.
We note that ν⋆ decreases with increasing refractory pe-
riod. For L = 200, we predict that the transition would
occur at ν⋆ ≈ 0.14 using δ = 0.05 and τ = 50. The cal-
culation of Prisk can be extended to multiple cell layers
(see supp. materials) and the abrupt transition remains.
Anti-arrhythmic drugs which prolong the refractory
period increase the wavelength of reentrant θ′ × τ ′,
thereby reducing the number of possible independent
electrical wavefronts which can propagate in the atrium.
This reduces the complexity of the fibrillation. However,
in addition to this, our model also predicts that prolong-
ing the refractory period τ→ τ˜ > τ reduces the structure-
related risk of inducing fibrillation by rendering once ar-
rhythmic regions, ν < ν⋆(τ), non-arrhythmic, ν > ν⋆(τ˜ ).
This implies that functional changes can render struc-
turally arrhythmic regions non-arrhythmic without ac-
tually modifying the structure.
The incidence of AF increases with age and is associ-
ated with the accumulation of fibrosis. Our objective was
to gain insight into the mechanisms responsible for the
initiation and maintenance of AF in this context using a
phenomenological model. This deliberately simple model
incorporates pertinent basic properties of tissue architec-
ture and electrical dysfunction, excluding electrophysio-
logical properties normally thought to be important in
fibrillation such as the dispersion of refractoriness and
restitution. The most interesting aspects of this study
are: (1) The mere simplicity of the model. (2) The in-
tegration of simplified dynamics on a relevant discrete
medium mimicking the anisotropic branching architec-
ture of heart muscle. (3) A single model that reproduces
multiple well known observed features of AF. (4) The
spontaneous emergence of AF (without external stim-
uli) when the transversal coupling is reduced, mimick-
ing fibrosis, beyond a threshold value. (5) Identification
of local critical regions initiating and maintaining AF.
(6) Analytical tractable risk of AF. (7) The existence of
an analytically tractable threshold value of heterogene-
ity below which AF emerges, providing insight into how
to control the risk. (8) A targeted ablation procedure is
possible for those patients at the early onset of AF driven
by fibrosis due to the small number of critical regions.
It would be of interest to investigate a non-uniform dis-
tribution of vertical coupling (e.g., localised fibrosis) or
refractory period [32]. The present model identifies spe-
cific targets for ablation based on the underlying struc-
ture of the myocardium. Patterned cultures of cardiac
myocyte monolayers or cardiac tissue slices could test
the primary predictions of the model as stated above. If
5the biological experiments agree with the model predic-
tions then such targets within a biological system might
be characterised electrophysiologically or architecturally
with the aim of translating such insight into clinical ap-
plications thereby, hopefully, improving the success rate
of treating AF with ablation.
Acknowledgements : We thank Zuzanna Zukowska for
helping implement the model. This work was supported
by the British Heart Foundation. Author Contribu-
tions : K.C. conceived the model. K.A.M. and K.C. per-
formed the analytic calculations. K.A.M. implemented
the model, collected and analysed the data and produced
the figures. N.S.P. provided advice on data analysis. All
authors contributed to writing the manuscript.
[1] K. T. Konings, C. J. Kirchhof, J. R. Smeets, H. J.
Wellens, O. C. Penn, and M. A. Allessie, Circulation 89,
1665 (1994).
[2] C. R. Kerr, K. H. Humphries, M. Talajic, G. J. Klein,
S. J. Connolly, M. Green, J. Boone, R. Sheldon, P. Do-
rian, and D. Newman, Am. Heart J. 149, 489 (2005).
[3] S. de Jong, T. A. B. van Veen, H. V. M. van Rijen,
and J. M. T. de Bakker, J. Cardiovasc. Pharm. 57, 630
(2011).
[4] J. M. Davidenko, A. V. Pertsov, R. Salomonsz, W. Bax-
ter, and J. Jalife, Nature (1992).
[5] S. M. Narayan, D. E. Krummen, K. Shivkumar, P. Clop-
ton, W. Rappel, and J. M. Miller, J. Am. Coll. Cardiol.
60, 628 (2012).
[6] M. S. Spach, Circ. Res. 101, 743 (2007).
[7] M. Haissaguerre, P. Ja¨ıs, D. C. Shah, A. Takahashi,
M. Hocini, G. Quiniou, S. Garrigue, A. Le Mouroux,
P. Le Me´tayer, and J. Cle´menty, New Engl. J. of Med.
339, 659 (1998).
[8] T. Satoh and D. P. Zipes, J. Cardiovasc. Electrophysiol.
7, 833 (1996).
[9] B. Kim, Y. Kim, G. Hwang, H. Pak, S. C. Lee, W. J.
Shim, D. J. Oh, and Y. M. Ro, J. Am. Coll. Cardiol. 39,
1329 (2002).
[10] J. Eckstein, S. Zeemering, D. Linz, B. Maesen, S. Ver-
heule, A. van Hunnik, H. Crijns, M. A. Allessie, and
U. Schotten, Circ. Arrhythm. Electrophysiol. p. 113
(2013).
[11] K. Nademanee, J. McKenzie, E. Kosar, M. Schwab,
B. Sunsaneewitayakul, T. Vasavakul, C. Khunnawat, and
T. Ngarmukos, J. Am. Col. Cardiol. 43, 2044 (2004).
[12] N. Wiener and A. Rosenblueth, Arch. I. Cardiol. Mex.
16, 205 (1946).
[13] G. K. Moe, W. C. Rheinboldt, and J. A. Abildskov, Am.
Heart J. 67, 200 (1964).
[14] G. Bub, A. Shrier, and L. Glass, Phys. Rev. Lett. 88,
058101 (2002).
[15] G. Bub, A. Shrier, and L. Glass, Phys. Rev. Lett. 94,
028105 (2005).
[16] G. Bub and A. Shrier, Chaos 12, 747 (2002).
[17] M. S. Spach and P. C. Dolber, Circ. Res. 58, 356 (1986).
[18] R. H. Clayton, O. Bernus, E. M. Cherry, H. Dierckx,
F. H. Fenton, L. Mirabella, A. V. Panfilov, F. B. Sachse,
G. Seemann, and H. Zhang, Prog. Biophys. Mol. Biol.
104, 22 (2011).
[19] R. H. Clayton, Physiol. Meas. 15 (2001).
[20] J. Sundnes, B. F. Nielsen, K. A. Mardal, X. Cai, G. T.
Lines, and A. Tveito, Ann. Biomed. Eng. 34, 1088
(2006).
[21] J. P. Keener, SIAM J. Appl. Math. 46, 1039 (1986).
[22] J. P. Keener, Physica D 31, 269 (1988).
[23] I. V. Biktasheva, D. Barkley, V. N. Biktashev, G. V.
Bordyugov, and A. J. Foulkes, Phys. Rev. E 79, 056702
(2009).
[24] M. S. Spach and M. E. Josephson, J. Cardiovasc. Electr.
5, 182 (1994).
[25] M. S. Spach and J. P. Boineau, Pacing Clin. Electrophys-
iol. 20, 397 (1997).
[26] M. S. Spach, Int. J. Bifurcat. Chaos 6, 1637 (1996).
[27] R. M. Lang, M. Bierig, R. B. Devereux, F. A. Flach-
skampf, E. Foster, P. A. Pellikka, M. H. Picard, M. J.
Roman, J. Seward, J. S. Shanewise, et al., J. Am. Soc.
Echocardiog. 18, 1440 (2005).
[28] A. Maceira, J. Cos´ın-Sales, M. Roughton, S. Prasad, and
D. Pennell, J. Cardiovasc. Magn. Reson. 12, 65 (2010).
[29] R. A. Luke and J. E. Saffitz, J. Clin. Invest. 87, 1594
(1991).
[30] S. Verheule, E. Wilson, T. Everett, S. Shanbhag,
C. Golden, and J. Olgin, Circulation 107, 2615 (2003).
[31] K. Nakamura, N. Funabashi, M. Uehara, M. Ueda,
T. Murayama, H. Takaoka, and I. Komuro, Int. J. Car-
diol. 148, 139 (2011).
[32] V. Krinskii, Biophys-USSR 11, 776 (1966).
